Literature DB >> 8315107

The incidence of isolation of methicillin-resistant Staphylococcus aureus (MRSA) strains from skin infections during the past three years (1989-1991).

S Nishijima1, S Namura, K Mitsuya, Y Asada.   

Abstract

We did a statistical study of 294 strains of Staphylococcus aureus (S. aureus) isolated from skin infections during the period from January of 1989 to December of 1991 in the Department of Dermatology, Kansai Medical University Hospital. We especially examined methicillin-resistant S. aureus (MRSA) from the point of view of incidence, variety of skin infections with MRSA, coagulase type, phase type, and resistance against antimicrobial agents. The frequency of isolation of MRSA has been increasing. In 1991, the proportion of MRSA isolates among all S. aureus strains isolated from skin infections was 41.5%. MRSA was isolated most often from infectious decubitus. Coagulase type II and phage group NT (not typable) MRSA were most frequently isolated. The resistance of MRSA to OFLX and IMP/CS had remarkably increased. Notably, the resistance to MINO was low before 1991.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8315107     DOI: 10.1111/j.1346-8138.1993.tb03860.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  3 in total

1.  In vitro activity of nadifloxacin against both methicillin-susceptible and -resistant clinical isolates of Staphylococcus aureus from patients with skin infections.

Authors:  S Nishijima; S Namura; H Akamatsu; S Kawai; Y Asada; S Kawabata; M Fujita
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 2.  Anti-microbial photodynamic therapy: useful in the future?

Authors:  Tim Maisch
Journal:  Lasers Med Sci       Date:  2006-11-21       Impact factor: 2.555

3.  The clinical spectrum and antibiotic sensitivity patterns of staphylococcal pyodermas in the community and hospital.

Authors:  Shireen Furtado; Ramesh M Bhat; B Rekha; D Sukumar; Ganesh H Kamath; Jacintha Martis; B Nandakishore
Journal:  Indian J Dermatol       Date:  2014-03       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.